An Open, Single-center, Phase 1 Study to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Pharmicell
- 05 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2016 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 07 Jul 2016 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.